An ongoing dialogue on HIV/AIDS, infectious diseases,
August 12th, 2021
Could This Be Our First Effective, Inexpensive, Widely Available Outpatient Treatment for COVID-19?
It’s fluvoxamine. This rarely used antidepressant, long off-patent, has quietly been going through high-quality clinical studies for treatment of COVID-19. It certainly won’t be endorsed or promoted by any deep-pocketed pharmaceutical company, but deserves some attention nonetheless. Here’s why I think we might finally be onto something with this “repurposed” drug, even after stumbling numerous […]
August 2nd, 2021
Provincetown July Celebration a Challenging Stress Test for the COVID-19 Vaccines
When the complete history of the COVID-19 pandemic is eventually written — and boy oh boy, can’t wait for that — certain events will feature prominently as sites of notable outbreaks. The Diamond Princess cruise ship The Biogen Leadership conference The Skagit Valley Chorale practice The Sturgis motorcycle rally The Amy Coney Barrett White House […]
Paul E. Sax, MD
Associate Editor
NEJM Clinician
Biography | Disclosures & Summaries
Learn more about HIV and ID Observations.